The Biden administration sends medical experts to the site of the derailed train carrying hazardous materials in Ohio; senators push for pharmacy benefit manager (PBM) reforms; Kentucky Supreme Court proceeds with near-total abortion ban.
Amid growing public safety concerns since a train carrying hazardous materials, including vinyl chloride, derailed in Ohio last week, the Biden administration has sent medical experts to assess any dangers to residents, according to CNN. An evacuation order that was sent in place has been lifted as of February 8. However, some residents are worried the testing is insufficient, as some individuals report smelling a chemical odor, headaches, and sore throats, and officials estimate thousands of fish killed by contamination were found downstream and in rivers.
During a heated hearing by the Senate Commerce Committee on Thursday, some Republican lawmakers accused pharmacy benefit managers (PBMs) of lacking transparency when directing patients toward pharmacies they own, according to Fierce Healthcare. In the hearing, pharmacies testified against contracts with PBMs, saying they have “zero negotiating power.” On the other hand, the Pharmaceutical Care Management Association, a PBM industry group, has pushed back on proposed legislation, blaming drug companies of “evergreening” and “patent thickets” that are blocking competitive drug prices.
On Thursday, Kentucky’s Supreme Court refused to overturn a near-total ban on abortion since the overturning of Roe v Wade, according to the Associated Press. Kentucky’s high court weighed in on issues concerning a statewide near-total abortion ban and an abortion ban after the sixth week of pregnancy. After voters rejected a ballot last year that would have denied any constitutional abortion protections, Republican legislation passed both laws.
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More